2 Giralda Farms • Madison, NJ 07940 • merck-animal-health-usa.com • 800-521-5767
Copyright © 2021 Intervet Inc., d/b/a/ Merck Animal Health, a subsidiary of Merck & Co., Inc.
All rights reserved.
The Science of
CONVENIENT
Ask your Merck Animal Health Equine representative
about PROTAZIL
®
or call 800-521-5767.
1
Hunyadi L, Papich MG, Pusterla N. Pharmacokinetics of a
low‑dose and DA‑labeled dose of diclazuril administered
orally as a pelleted top dressing in adult horses. J of Vet
Pharmacology and Therapeutics (accepted) 2014, doi:
10.111/jvp.12176. The correlation between pharmacokinetic
data and clinical effectiveness is unknown
• Equine Protozoal Myeloencephalitis (EPM) is a serious
neurological disease that can strike anytime, anywhere.
Make treatment easy with PROTAZIL
®
• Safe and accurate dosing with a calibrated scoop
• Easier to use than paste, less stress for you
and your horse
• Rapid absorption — no loading dose required
1
Now that's convenient.
PROTAZIL
®
(1.56% diclazuril) Antiprotozoal Pellets
is the only FDA-approved alfalfa-based top dress
antiprotozoal pellet for the treatment of EPM.
IMPORTANT SAFETY INFORMATION: Use of PROTAZIL
®
(1.56% diclazuril)
Antiprotozoal Pellets is contraindicated in horses with known hypersensitivity
to diclazuril. Safe use in horses used for breeding purposes, during pregnancy, or in
lactating mares has not been evaluated. The safety of PROTAZIL
®
(1.56% diclazuril)
Antiprotozoal Pellets with concomitant therapies in horses has not been evaluated.
For use in horses only. Do not use in horses intended for human consumption.
Not for human use. Keep out of reach of children.
